UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Equity Markets
This Equity Markets page curates three articles on CrowdStrike, KKR, and Salesforce, showing how big moves affect stock prices and your portfolio.
12 articles
Carvana Price Target Adjusted to $93 as Retail Volumes Hold
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
Investment Counsel Cashes $10.5 Million: Market Moves and Implications
When a trusted investment firm unloads a large stake, markets take notice. This article breaks down a real-world exit...
Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Alibaba Price Target Slashed as AI Push Drags Profits Lower
A major broker cuts Alibaba's target to $170 after a sharp drop in Q3 profits, driven by heavy AI investment. The clo...
Raymond James Targets $290 on Valero, Citing Margin Gains
Raymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
Wall Street Pros Upside Seen for Royal Caribbean Stock
Analysts see a wall street pros upside for Royal Caribbean as 2026 capacity and earnings guidance point to a stronger...
Core Question Freshworks Investors: Buyback Versus AI Risk
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
Down Almost Week, This: Is Starbucks Stock a Buy?
Starbucks shares have slipped sharply in a single week. This guide breaks down what’s driving the move, how to assess...
KKR’s CEOs Bought 175,000 Shares Amid Retail Selloff
Two KKR Co-CEOs bought a combined 175,000 shares in February, signaling confidence as the stock trades in the mid-$90...
Salesforce’s Record Billion Stock-Buyback Sparks Debate
Salesforce unveils a $50 billion buyback as software stocks waver, triggering a fierce debate over whether capital sh...
Why CrowdStrike Plunged Second Day in a Row: Key Takeaways
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...